Contemporary optimized practice in the management of pulmonary sarcoidosis по Shambhu Aryal, Steven D. Nathan

Полный текст

Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study по Min Jee Kim, Steven D. Nathan, Hyeon Hwa Kim, Ho Cheol Kim

Полный текст

Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis по Tracey Weiss, Aimee M. Near, Xiaohui Zhao, Dena Rosen Ramey, Tania Banerji, Handing Xie, Steven D. Nathan

Полный текст

The 6-min walk test as a primary end-point in interstitial lung disease по Sergio Harari, Athol U. Wells, Wim A. Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

Полный текст

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Dev... по Steven D. Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari, Katerina Antoniou, Sylvia M. Nikkho, Norman Stockbridge

Полный текст

COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT study по Steven D. Nathan, Victoria Lacasse, Heidi Bell, Prakash Sista, Michael Di Marino, Todd Bull, Victor Tapson, Aaron Waxman

Полный текст

Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database по Steven D. Nathan, Scott D. Barnett, Christopher S. King, Steeve Provencher, Joan A. Barbera, Jean Pastre, Oksana A. Shlobin, Werner Seeger

Полный текст

HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelines по Steven D. Nathan, Jean Pastre, Inga Ksovreli, Scott Barnett, Christopher King, Shambhu Aryal, Kareem Ahmad, Cesar Fukuda, Vijaya Ramalingam, Jonathan H. Chung

Полный текст

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Inn... по Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John A. Scandurra, Paul M. Hassoun, Sylvia M. Nikkho, Steven D. Nathan

Полный текст

Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real‐world data analysis по Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan

Полный текст

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis по Vincent Cottin, Steven D Nathan, Lisa Lancaster, Peter Smith, Kevin R Flaherty, Jürgen Behr, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson

Полный текст

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis по Christopher Thomas, Abhimanyu Chandel, Christopher S. King, Shambhu Aryal, A. Whitney Brown, Vikramjit Khangoora, Alan Nyquist, Anju Singhal, Onix Cantres Fonseca, Oksana Shlobin, Steven D. Nathan

Полный текст

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis по Abhimanyu Chandel, Christopher S. King, Rosalinda V. Ignacio, Jean Pastre, Oksana A. Shlobin, Vikramjit Khangoora, Shambhu Aryal, Alan Nyquist, Anju Singhal, Kevin R. Flaherty, Steven D. Nathan

Полный текст

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository по Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan

Полный текст

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease по Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek

Полный текст

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension по Abhimanyu Chandel, Alison Verster, Husna Rahim, Vikramjit Khangoora, Steven D. Nathan, Kareem Ahmad, Shambhu Aryal, Aaron Bagnola, Anju Singhal, A. Whitney Brown, Oksana A. Shlobin, Christopher S. King

Полный текст

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Inst... по Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John Wort

Полный текст

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis по Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel

Полный текст

Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung disease по Ho Cheol Kim, MD, Onix Cantres Fonseca, MD, Behnam N. Tehrani, MD, Christopher S. King, MD, Christopher Thomas, MD, Vikramjit Khangoora, MD, Oksana A. Shlobin, MD, Steven D. Nathan, MD

Полный текст

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry по Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney

Полный текст